Ottawa Hospital Research Institute
🇨🇦Canada
Safe Effective Therapy With Low-Dose Glucocorticoid in ANCA-Associated Vasculitis (SAFE-LOW)
Phase 3
Not yet recruiting
- Conditions
- Granulomatosis With PolyangiitisMicroscopic Polyangiitis (MPA)
- Interventions
- First Posted Date
- 2025-05-21
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- Ottawa Hospital Research Institute
- Target Recruit Count
- 36
- Registration Number
- NCT06983821
- Locations
- 🇨🇦
St-Joseph's Hospital, Hamilton, Ontario, Canada
🇨🇦The Ottawa Hospital, Ottawa, Ontario, Canada
A Pilot Trial Comparing Full Dose Rivaroxaban to Prophylactic Dose Rivaroxaban in Patients With Superficial Vein Thrombosis in the Leg
Phase 2
Not yet recruiting
- Conditions
- SVTThrombosisSuperficial Vein Thrombosis
- Interventions
- Drug: Full dose rivaroxabanDrug: Low dose rivaroxaban and placebo
- First Posted Date
- 2025-05-11
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- Ottawa Hospital Research Institute
- Target Recruit Count
- 50
- Registration Number
- NCT06965998
- Locations
- 🇨🇦
The Ottawa Hospital, Ottawa, Ontario, Canada
🇨🇦Hopital Montfort, Ottawa, Ontario, Canada
Do Blood Tests Help to Decide Which Patients With Flares of Chronic Obstructive Pulmonary Disease (COPD) Need Antibiotics and Steroids?
Phase 4
Not yet recruiting
- Conditions
- Chronic Obstructive Pulmonary DiseaseAECOPDCOPDExacerbation of COPDECOPD
- First Posted Date
- 2025-04-16
- Last Posted Date
- 2025-04-16
- Lead Sponsor
- Ottawa Hospital Research Institute
- Target Recruit Count
- 80
- Registration Number
- NCT06929767
- Locations
- 🇨🇦
The Ottawa Hospital, Ottawa, Ontario, Canada
Characterizing Postoperative T and B Cell Dysfunction in Cancer Surgery Patients, Using COVID-19 as a Model Antigen
Completed
- Conditions
- Abdominal Cancer
- First Posted Date
- 2025-04-13
- Last Posted Date
- 2025-04-13
- Lead Sponsor
- Ottawa Hospital Research Institute
- Target Recruit Count
- 30
- Registration Number
- NCT06925906
- Locations
- 🇨🇦
The Ottawa Hospital, Ottawa, Ontario, Canada
Development of a Risk Stratification Score for Recurrent Venous Thromboembolism and Treatment-related Clinically Relevant Bleeding in Patients With Cancer-associated Thrombosis
Recruiting
- Conditions
- Cancer-associated Thrombosis
- First Posted Date
- 2025-03-25
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- Ottawa Hospital Research Institute
- Target Recruit Count
- 1000
- Registration Number
- NCT06894576
- Locations
- 🇨🇦
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
The Feasibility and Efficacy of Dose Timing (Morning vs Evening) of Temozolomide in the Treatment of Glioblastoma
Not Applicable
Recruiting
- Conditions
- IDH-Wildtype GlioblastomaGlioblastoma (GBM)
- First Posted Date
- 2025-02-27
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Ottawa Hospital Research Institute
- Target Recruit Count
- 50
- Registration Number
- NCT06850766
- Locations
- 🇨🇦
London Health Sciences Centre, London, Ontario, Canada
🇨🇦The Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada
Use of Phage Therapy for Treatment of a Periprosthetic Joint Infection
Phase 1
Active, not recruiting
- Conditions
- Periprosthetic Joint Infection
- Interventions
- Biological: Phage (Cytophage Technologies)
- First Posted Date
- 2025-02-14
- Last Posted Date
- 2025-02-14
- Lead Sponsor
- Ottawa Hospital Research Institute
- Target Recruit Count
- 1
- Registration Number
- NCT06827041
- Locations
- 🇨🇦
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
A Study to Evaluate Efficacy, Safety and Tolerability of Hydroxychloroquine in Subjects With Parkinson's Disease
Phase 2
Not yet recruiting
- Conditions
- Parkinson&Amp;#39;s Disease
- Interventions
- First Posted Date
- 2025-02-10
- Last Posted Date
- 2025-02-10
- Lead Sponsor
- Ottawa Hospital Research Institute
- Target Recruit Count
- 40
- Registration Number
- NCT06816810
- Locations
- 🇨🇦
The Ottawa Hospital, Ottawa, Ontario, Canada
Bacteriophage Clinical Trial for Periprosthetic Joint Infection of Multidrug Resistant Pseudomonas Aeruginosa
- Conditions
- Joint Infection
- First Posted Date
- 2025-01-29
- Last Posted Date
- 2025-01-29
- Lead Sponsor
- Ottawa Hospital Research Institute
- Registration Number
- NCT06798168
- Locations
- 🇨🇦
The Ottawa Hospital, Ottawa, Canada
Endoscopically Placed Lumen-Apposing Metal Stents for the Treatment of Symptomatic Intestinal Strictures in Individuals With Inflammatory Bowel Disease
Not Applicable
Not yet recruiting
- Conditions
- Inflammatory Bowel DiseasesStricture; Bowel
- First Posted Date
- 2024-12-10
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- Ottawa Hospital Research Institute
- Target Recruit Count
- 20
- Registration Number
- NCT06725563
© Copyright 2025. All Rights Reserved by MedPath